↓ Skip to main content

The application and prospect of CDK4/6 inhibitors in malignant solid tumors

Overview of attention for article published in Journal of Hematology & Oncology, May 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The application and prospect of CDK4/6 inhibitors in malignant solid tumors
Published in
Journal of Hematology & Oncology, May 2020
DOI 10.1186/s13045-020-00880-8
Pubmed ID
Authors

Qi Du, Xiang Guo, Miao Wang, Yongfu Li, Xiaoyi Sun, Qin Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 12%
Researcher 11 10%
Student > Master 10 9%
Student > Doctoral Student 8 7%
Student > Bachelor 7 6%
Other 14 13%
Unknown 48 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 23%
Medicine and Dentistry 15 14%
Chemistry 4 4%
Agricultural and Biological Sciences 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 7 6%
Unknown 52 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2023.
All research outputs
#3,388,533
of 24,483,002 outputs
Outputs from Journal of Hematology & Oncology
#288
of 1,264 outputs
Outputs of similar age
#79,390
of 381,759 outputs
Outputs of similar age from Journal of Hematology & Oncology
#11
of 40 outputs
Altmetric has tracked 24,483,002 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,264 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,759 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.